Lithium in neuropsychiatry: A 2010 update

References

• Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, . 2010. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 9:481–488.
   PubMed Web of Science ®Google Scholar
• Aminoff MJ, Marshall J. 1974. Treatment of Huntington's chorea with lithium carbonate: A double-blind trial. Lancet 7848: 107–109.
   Google Scholar
• Baldessarini RJ, Tondo L, Pompili M, Goodwin FK, Hennen J. 2007. Decreased risk of suicides and attempts during long-term lithium treatment: a meta analytic review. Bipolar Disord 8:625–639.
   Google Scholar
• , BALANCE investigators and collaboratorsGeddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, . 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open–label trial. Lancet 375:385–395.
   PubMedGoogle Scholar
• Baum AE, Akula N, Habanero M, Cardona I, Corona W, Klemens B, . 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13: 197–207.
   PubMed Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, Nicoletti M. 2007. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62:7–16.
   PubMed Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dutton RA, Frey BN, Peluso MA, Nicoletti M, . 2008. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 33: 1229–1238.
   PubMed Web of Science ®Google Scholar
• Bersudsky Y, Shaldubina A, Agam G, Berry GT, Belmaker RH. 2008. Homozygote inositol transporter knockout mice show a lithium-like phenotype. Bipolar Disord 10:453–459.
   Google Scholar
• Borkowska A, Rybakowski JK. 2001. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord 3:88–94.
   PubMed Web of Science ®Google Scholar
• Cade JF. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352.
   PubMed Web of Science ®Google Scholar
• Chio A, Borghero G, Calvo A, Capasso M, Caponetto C, Corbo M, . 2010. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology 75: 619–625.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Pretty H, Hawton K, Geddes JR. 2005. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805–1819.
   PubMed Web of Science ®Google Scholar
• Clark L, Iversen SD, Goodwin GM. 2002. Sustained attention deficit in bipolar disorder. Br J Psychiatry 180:313–319.
   PubMed Web of Science ®Google Scholar
• Crossley NA, Bauer M. 2007. Acceleration and augmentation of antidepressants with lithium for depressive disorders: Two meta-analyses of randomized controlled trials. J Clin Psychiatry 68:935–940.
   PubMed Web of Science ®Google Scholar
• Cruceanu C, Alda M, Turecki G. 2009. Lithium: a key to the genetics of bipolar disorder. Genome Med 1:79.
   PubMedGoogle Scholar
• Delay J, Deniker P, Harl JM. 1952. Utilisation en thérapeutique psychiatrique d'une phénothiazine d'action centrale élective. Ann Méd Psychol 110:112–117.
   PubMedGoogle Scholar
• De Montigny C, Grunberg F, Mayer A, Deschenes JP. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders. Br J Psychiatry 138:262–256.
   Google Scholar
• Dunn N, Holmes C, Mulee M. 2005. Does lithium therapy protect against the onset of dementia. Alzheimer Dis Assoc Disord 19:20–22.
   PubMed Web of Science ®Google Scholar
• Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, . 2008. Lithium delays progression of amyotrophic lateral sclerosis. Proc NY Acad Sci 105:2052–2057.
   Google Scholar
• Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopoulos P, Kaprinis G, . 2008. A systematic review of existing data on long-term lithium therapy: neuroprotective of neurotoxic? Int J Neuropsychopharmacol 11:269–287.
   PubMedGoogle Scholar
• Germana C, Kempton MJ, Sarnicola A, Christodoulou T, Haldane M, Hadjulis M, . 2010. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand 122:481–487.
   PubMed Web of Science ®Google Scholar
• Gershon S. 2010. Lithium: the long road. Bipolar Disord 12: 667–668.
   Google Scholar
• Gildengers AG, Mulsant BH, Begley A, Mazumdar S, Hyams AV, Reynolds CF, . The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord 11:7 44–752.
   Google Scholar
• Gill A, Kidd J, Vieira F, Thompson K, Perris S. 2009. No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinden trial using a standard mouse model of familial ALS. PLoS One 4:e6489.
   PubMedGoogle Scholar
• Grof P. 1999. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. Birch NJ, Gallicchio VS, Becker RW. Lithium: 50 years of psychopharmacology, new perspectives in biomedical and clinical research. Cheshire, CT: Weidner Publishing Group. 36–51.
   Google Scholar
• Grof P. 2010. Sixty years of lithium responders. Neuropsychobiology 62:8–16.
   Google Scholar
• Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A, . 2009. Lithium trial in Alzheimer's disease: a randomized, single blind, placebo controlled, multicenter 10-week study. J Clin Psychiatry 70:922–931.
   PubMed Web of Science ®Google Scholar
• Hartigan G. 1963. The use of lithium salts in affective disorders. Br J Psychiatry 109:810–814.
   PubMed Web of Science ®Google Scholar
• Hirschowitz J, Kolevzon A, Garakani A. 2010. Pharmacological treatment of bipolar disorder: the question of modern advances. Harv Rev Psychiatry 18:266–278.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Fernandes BS, Kauer-Sant'Anna M, Gama CS, Yatham LN, Berk M. 2009. The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers. Acta Neuropsychiatr 21:272–274.
   Google Scholar
• Kessing LV, Sondergard L, Forman JL, Andersen PK. 2008. Lithium treatment and the risk of dementia. Arch Gen Psychiatry 65:1331–1335.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Forman JL, Andersen PK. 2010. Does lithium protect against dementia? Bipolar Disord 12:97–94.
   Web of Science ®Google Scholar
• Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, . 2008. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomized, placebo controlled, 1-year trial. Acta Psychiatr Scand 118:469–479.
   PubMed Web of Science ®Google Scholar
• Leonard DP, Kidson MA, Brown JG, Shannon PJ, Taryan S. 1975. A double blind trial of lithium carbonate and haloperidol in Huntington's chorea. Aust NZ J Psychiatry 9:115–118.
   PubMed Web of Science ®Google Scholar
• Leroy K, Ando K, Heraud C, Yilmaz Z, Authelet M, Boeynaems JM, . 2010. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. J Alzheimers Dis 19:705–719.
   PubMed Web of Science ®Google Scholar
• Li X, Liu M, Cai Z, Wang G, Li X. 2010. Regulation of glycogen synthase kinase-3 during bipolar mania treatment. Bipolar Disord 12:741–752.
   PubMed Web of Science ®Google Scholar
• Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, Coryell W, . 2008. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Gen 18: 267–274.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo C, Lopera-Vasquez J, Ospina Duque J, Garcia J, Gallo A, Cortez V, . 2010. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 71:1055–1060.
   Web of Science ®Google Scholar
• Lyoo K, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, . 2010. Lithium-induced grey matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology 35:1743–1750.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Manji HK, Zarate CA. 2009. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2):92–109.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Adams D, Berk M. 2009. Is lithium in a class of its own? A brief profile of its clinical use. Aust NZ J Psychiatry 43:1096–1104.
   PubMed Web of Science ®Google Scholar
• McBride SMJ, Choi C, Schoenfeld BP, Bell AJ, Liebelt DA, Ferreiro D, . 2010. Pharmacological and genetic reversal of age-dependent cognitive deficits attributable to decreased presenilin function. J Neurosci 30:9510–9522.
   Google Scholar
• Mendes CT, Mury FB, de Sa Moreira E, Alberto FL, Forlenza OV, Dias-Neto E, . 2009. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 259:16–22.
   PubMed Web of Science ®Google Scholar
• Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M, . 2007. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett 429:7–11.
   Google Scholar
• Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. 2000. Lithium-induced increase in human brain grey matter. Lancet 356:1241–1242.
   PubMed Web of Science ®Google Scholar
• Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, . 2009. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 70:699–705.
   PubMed Web of Science ®Google Scholar
• Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. 2007. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as core deficit. J Clin Psychiatry 68:1078–1086.
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Lewitzka U. 2010. Lithium reduces pathological aggression and suicidality: A mini-review. Neuropsychobiology 62:43–49.
   Google Scholar
• Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, . 1992. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatr Scand 86:218–222.
   PubMed Web of Science ®Google Scholar
• Nivoli AMA, Murru A, Vieta E. 2010. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology 62:27–35.
   PubMed Web of Science ®Google Scholar
• Nocjar C, Hammonds MD, Shim SS. 2007. Chronic lithium treatment magnifies learning in rats. Neuroscience 150:774–788.
   PubMedGoogle Scholar
• Nunes PV, Forlenza OV, Gattaz WF. 2007. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry 190:359–360.
   PubMed Web of Science ®Google Scholar
• Ohgami H, Terao T, Shiotsuki I, Nobuyoshi I, Iwata N. 2009. Lithium levels in drinking water and risk of suicide. Br J Psychiatry 194:464–465.
   PubMed Web of Science ®Google Scholar
• Pizzasegola C, Caron I, Daleno C, Ronchi A, Minola C, Carri MT, . 2009. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph Lateral Scler 10:221–228.
   PubMed Web of Science ®Google Scholar
• Quiroz JA, Machado-Vieira R, Zarate CA, Manji HK. 2010. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62:50–60.
   PubMed Web of Science ®Google Scholar
• Rybakowski J, Matkowski K. 1992. Adding lithium to antidepressant therapy:factors related to therapeutic potentiation. Eur Neuropsychopharmacol 2:161–165.
   PubMedGoogle Scholar
• Rybakowski JK, Suwalska A. 2010. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 13:617–622.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. 2001. The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord 3:63–67.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, . 2005. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38: 166–170.
   PubMedGoogle Scholar
• Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. 2007. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am J Med Genet B Neuropsychiatry Genet 144B:820–823.
   PubMedGoogle Scholar
• Rybakowski JK, Permoda-Osip A, Borkowska A. 2009. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol 19:791–795.
   PubMedGoogle Scholar
• Sarkar S, Krishna G, Imarisio S, Saiki S, O'Kane CJ, Rubinsztein DC. 2008. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum Mol Genet 17:170–178.
   PubMed Web of Science ®Google Scholar
• Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, . 2010. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium prophylaxis. Neuropsychobiology 62:72–78.
   PubMedGoogle Scholar
• Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM. 2004. Short-term lithium treatment promotes neuronal survival and proliferation in rata striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol Psychiatry 9:371–385.
   PubMed Web of Science ®Google Scholar
• Shin JH, Cho SI, Lim HR, Lee JK, Lee YA, Noh JS, . 2007. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol Pharmacol 71:965–975.
   PubMedGoogle Scholar
• Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu B, . 2007. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 9(Suppl 1):136–144.
   PubMedGoogle Scholar
• Smith DJ, Evans R, Craddock N. 2010. Predicting response to lithium in bipolar disorder: A critical review of pharmacogenetic studies. J Ment Health 19:142–156.
   Web of Science ®Google Scholar
• Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C. 2010. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet 6:pii:e1001087.
   Google Scholar
• Vestergaard P, Baastrup PC, Petersson H. 1977. Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial. Acta Psychiatr Scand 56:183–186.
   PubMed Web of Science ®Google Scholar
• Watase K, Gatchel JR, Sun Y, Emamian E, Atkinson R, Richman R, . 2007. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse. PLoS Med 4:e182.
   PubMed Web of Science ®Google Scholar
• Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. 2009. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 70:1588–1597.
   PubMed Web of Science ®Google Scholar
• Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, . 2006. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 66:11179–11186.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Guleryuz S, Ankerst DP, Obgur D, Renshaw PF. 2008. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen psychiatry 65:255–263.
   PubMed Web of Science ®Google Scholar
• Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT. 2007. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology 195: 357–367.
   PubMedGoogle Scholar
• Yucel K, Taylor VH, McKinnon MC, Macdonald K, Alda M, Young LT. 2008. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 13:361–367.
   Google Scholar